Incidence of infective endocarditis in patients considered at moderate risk

Autor: Mohsin Aslam, Emil L. Fosbøl, Lauge Østergaard, Henning Bundgaard, G G Gislason, Lars Køber, Niels Eske Bruun, Lars Søndergaard, Andrew Wang, Nana Valeur, Christian Torp-Pedersen
Rok vydání: 2018
Předmět:
Male
medicine.medical_specialty
Denmark
Population
Heart Valve Diseases
030204 cardiovascular system & hematology
Lower risk
Risk Assessment
Heart valve disorder
03 medical and health sciences
0302 clinical medicine
Risk Factors
Internal medicine
Humans
Medicine
Cumulative incidence
Registries
030212 general & internal medicine
education
Aged
Aged
80 and over

Heart Valve Prosthesis Implantation
education.field_of_study
Endocarditis
business.industry
Incidence
Hazard ratio
Hypertrophic cardiomyopathy
Endocarditis
Bacterial

Cardiomyopathy
Hypertrophic

Middle Aged
medicine.disease
Defibrillators
Implantable

Aortic Valve
Case-Control Studies
Heart Valve Prosthesis
Infective endocarditis
Cardiology
Mitral Valve
Mitral Valve Disorder
Female
Moderate-risk patients
Cardiology and Cardiovascular Medicine
business
Follow-Up Studies
Endocarditis prophylaxiss
Zdroj: Østergaard, L, Valeur, N, Wang, A, Bundgaard, H, Aslam, M, Gislason, G, Torp-Pedersen, C, Bruun, N E, Søndergaard, L, Køber, L & Fosbøl, E L 2019, ' Incidence of infective endocarditis in patients considered at moderate risk ', European Heart Journal, vol. 40, no. 17, pp. 1355–1361 . https://doi.org/10.1093/eurheartj/ehy629
ISSN: 1522-9645
0195-668X
DOI: 10.1093/eurheartj/ehy629
Popis: Aims Stratification of patients at risk of infective endocarditis (IE) remains a cornerstone in guidance of prophylactic strategies of IE. However, little attention has been given to patients considered at moderate risk. Methods and results Using Danish nationwide registries, we assessed the risk of IE in patients with aortic and mitral valve disorders, a cardiac implantable electronic device (CIED), or hypertrophic cardiomyopathy (HCM) and compared these patient groups with (i) controls from the background population using risk-set matching and (ii) a high-risk population (prosthetic heart valve). Cumulative incidence plots and multivariable adjusted Cox proportional hazard analysis were used to compare risk of IE between risk groups. We identified 83 453 patients with aortic or mitral valve disorder, 50 828 with a CIED, and 3620 with HCM. The cumulative risk of IE after 10 years was 0.9% in valve disorder, 1.3% in CIED, and 0.5% in HCM patients. Compared with the background population, valve disorder, CIED, and HCM carried a higher associated risk of IE, hazard ratio (HR) = 8.75 [95% confidence interval (CI) 6.36–12.02], HR = 6.63 (95% CI 4.41–9.96), and HR = 6.57 (95% CI 2.33–18.56), respectively. All three study groups were associated with a lower risk of IE compared with high-risk patients, HR = 0.27 (95% CI 0.23–0.32) for valve disorder, HR = 0.28 (95% CI 0.23–0.33) for CIED, and HR = 0.13 (95% CI 0.06–0.29) for HCM. Conclusions Heart valve disorder, CIED, and patients with HCM were associated with a higher risk of IE compared with the background population but have a lower associated risk of IE compared with high-risk patients.
Databáze: OpenAIRE